Comparative efficacy and safety of atorvastatin, simvastatin and lovastatin in the management of dyslipidemic Type 2 diabetic patients

By Hadjibabaie Molouk   Gholami Kheirollah   Khalili Hossain   Khoei Seyed Hamid   Nakhjavani Manoochehr   Rayati Kobra   Tohidi Atefeh   Rahimi Roja   Abdollahi Mohammad  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 759-764

Future Medicine

Access to resources Recommend Favorite

Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial

By Techapornroong Malee   Suankratay Chusana  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 10, 2007-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 699-702

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors affecting the efficacy of starting insulin treatment in Type 2 diabetic patients

By Vähätalo Markku   Rönnemaa Tapani   Viikari Jorma  

Scandinavian Journal of Primary Health Care, Vol. 21, Iss. 4, 2003-12 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis

By Gotfried Mark   Notario Gerard   Spiller Joy   Palmer Robert   Busman Todd  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 245-254

Informa Healthcare

Access to resources Recommend Favorite